The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Improving our knowledge about a new plug-based vascular closure device

EuroIntervention 2019;15:25-27. DOI: 10.4244/EIJV15I1A4

1. Groupe CardioVasculaire Interventionnel, Clinique Pasteur, Toulouse, France
The year 2019 has ushered in new insights concerning transcatheter aortic valve implantation (TAVI). We learnt that this treatment could be equal or even superior to surgery in low-risk patients in terms of mortality, stroke, rehospitalisation and bleeding1,2. This reflects the improvement observed since the first-in-man case in 2002. We have witnessed a constant evolution in the devices utilised with better profiles, repositionability, more stable deployment, sealing features and a wider range of treatable annuli3. Various aspects of the procedure have also evolved during the last decade including (non-exhaustively) the use of cerebral protection devices, radial artery as the accessory access site ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Should we stop using bioresorbable scaffolds in coronary revascularisation?